Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer.

Enrico PotenzaGiulia ParpinelMaria E LaudaniChiara MacchiLuca FusoPaolo Zola

Published in: The International journal of biological markers (2020)

We can conclude that the monitoring of HE4 and Ca125 during chemotherapy, especially at the third cycle, is recommended, because their variation is a good prognostic factor.

Keyphrases

prognostic factors
locally advanced
protein kinase
squamous cell carcinoma
chemotherapy induced
rectal cancer